The FHI is now assessing whether it will withstand the dose of the vaccine for people with COVID-19.
The vaccine from Pfizer and Moderna is usually given in two doses to get the best possible effect. The FHI is now considering whether just one dose might be sufficient for some groups.
`` We are currently looking at whether people who have previously received covid-19 will have adequate protection after giving one dose of the vaccine. There is data that young and healthy have a good effect after the first dose. This is FHI vaccine analysis expert Sara Sofie
The ability to give just one dose to survivors may allow another dose of vaccine to be given to others. The FHI believes the infection is acting as the number one vaccine dose.
"The dose of vaccine they get after they get sick will then give a so-called booster response, which is similar to what they'll get after the second dose," says Viksmoen Watle.
This mainly applies to people outside the risk group.
Still many unknowns
If COVID-19 can come back, how long will it last?
vaccine immunity? How is the length of the resistance obtained as a result of
vaccinations?
We do not have long observations here, because COVID-19 is a disease we are dealing with
for less than a year. Everyone is following 2-3 months from phase III trials - and it is difficult from them
say more. However, as he observes in clinical trials, information from various sources. There will be continued monitoring of those people who got the vaccine and we will have more every month
a better understanding of how long antibodies last. How long are we secured
before the disease. On the part of ECDC, population studies will be coordinated as they will
lead many countries on large populations. Doctors have been preparing for this for a long time. WITH
each month we will have a better knowledge of the security offered by these
vaccinations. The theoretical possibility is that if resistance decreases, they will be needed
booster doses. Lukasz Pawlowicz
